Skip to content

To find out presence of Human Papillomavirus(HPV) infection and HPV-related diseases in HIV-positive men who have sex with other men

Investigating Human Papillomavirus (HPV) Infection and HPV-associated Disease in Indian Men who have Sex with Men who are HIV-positive

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/09/045981
Enrollment
246
Registered
2022-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Sponsors

Department of Health Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Men age 18 or older. 2. HIV positive, as documented by any licensed HIV test according to the Indian National AIDS Control Organization (NACO) guidelines. 3. Participants report any sex with a man in the past 6 months. 4. Participants must speak Hindi, Marathi, or English. 5. Participants should not have any plans to move out of the area in the next 12 months and commit to attending two additional visits one at 6 months and one at 12 months.

Exclusion criteria

Exclusion criteria: 1. Active drug or alcohol use or dependence, or other impairment that, in the opinion of the site Investigator, would interfere with adherence to study requirements. (Participants with impairments that, in the opinion of the site Investigator, are temporary, will be asked to return another day for enrollment.) 2. Inability to provide informed consent. 3. History of a sex change operation that would preclude collection of penile or scrotal specimens.

Design outcomes

Primary

MeasureTime frame
Determine the prevalence of HPV-associated premalignant lesions in the anus and penis in Indian HIV-seropositive men who have sex with men (MSM). Timepoint: 52 weeks

Secondary

MeasureTime frame
1.Describe risk factors for prevalent premalignant lesions in the anus and penis in Indian HIV-seropositive MSM. 2. Describe the prevalence and incidence of penile and anal HPV infection in Indian HIV-seropositive MSM.Timepoint: 52 weeks

Countries

India

Contacts

Public ContactSharmila Pimple

Tata Memorial Hospital

pimplesa@tmc.gov.in9223207939

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026